| Identification | Back Directory | [Name]
Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH | [CAS]
133575-43-6 | [Synonyms]
Fmoc-Thr(GalNAc(Ac)3-b-D)-OH
Fmoc-Thr(GalNAc(Ac)?-β-D)-OH
Fmoc-L-Thr(2-D-GalNAc(Ac)3)-OH | [Molecular Formula]
C33H38N2O13 | [MDL Number]
MFCD30748647 | [MOL File]
133575-43-6.mol | [Molecular Weight]
670.66 |
| Chemical Properties | Back Directory | [Boiling point ]
857.1±65.0 °C(Predicted) | [density ]
1.38±0.1 g/cm3(Predicted) | [pka]
3.32±0.10(Predicted) | [Sequence]
Fmoc-{Thr(GalNAc(Ac)3-β-D)}-OH |
| Hazard Information | Back Directory | [Uses]
Fmoc-Thr(GalNAc(Ac)3-β-D)-OH inhibits cancer cell growth, through targeting intricate cancer-specific pathways while simultaneously strengthening immunologic response[1]. | [References]
[1] Levi S Simpson, et al. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides. Chem Biol. 2009 Feb 27;16(2):153-61. DOI:10.1016/j.chembiol.2008.12.007 |
|
| Company Name: |
Bachem AG
|
| Tel: |
+41 61 935 2323 |
| Website: |
www.bachem.com |
|